VANCOUVER, British Columbia, July 16, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that it is pursuing a listing on the Capital Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) to enhance the Company’s investor profile... Read more
Silo Pharma Enters into Sponsored Research Agreement with the University of Maryland, Baltimore
July 15, 2021
Englewood Cliffs NJ, July 12, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a development stage biopharmaceutical company, today announced that it has entered into a Scientific Research Agreement with the University of Maryland, Baltimore. The main objective of our study is to evaluate the pharmacokinetics of dexamethasone... Read more
Ryan Allway July 13th, 2021 Psychedelics, Top News Calgary, Alberta – July 13, 2021. For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) reports filing of a patent application at the United States Patent and Trademark Office (USPTO). MedX (CSE: MXT, OTC:MXTTF) reports that it... Read more
Family Office Networks announced today the official launch of the exclusive Family Office Cannabis Investment Club as a membership-only group designed to help family offices and other ultra-high net worth investors to get access to unique deal flow and due diligence on private and public cannabis deals and funds in a... Read more
“I am excited that we are adding these six new locations which will bring High Tide’s total retail footprint in Saskatchewan to ten stores upon completion and solidify our position as a leading cannabis retailer in the province,” said Raj Grover, High Tide’s President & Chief Executive Officer. “Furthermore, within the City... Read more
Ryan Allway July 8th, 2021 Psychedelics, Top News Enveric Enters into Clinical Stage Development of Lead Asset, EV101, in Israel with MOH Approval NAPLES, Fla., July 8, 2021 /PRNewswire/ — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, announced... Read more
Ryan Allway July 7th, 2021 Psychedelics, Top News VANCOUVER, British Columbia, July 07, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“ Ketamine One ” or the “ Company ”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0) , a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased... Read more
Decibel Announces Strategic Partnership to Bring US Brand Dabstract, and Exclusive Product Formulations to Canada
July 7, 2021
Ryan Allway July 7th, 2021 News, Top News CALGARY, AB, July 7, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce that it entered into a strategic partnership with Union Cannabis Group (“UCG”). Under the strategic partnership, Decibel has... Read more
Ryan Allway July 6th, 2021 Psychedelics, Top News Dr. Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid July 06, 2021 08:30 ET | Source: Ehave MIAMI, July 06, 2021... Read more
MedXtractor Fills a Key Gap in Mental Health Treatments
June 30, 2021
Ryan Allway June 30th, 2021 App, Exclusive, Psychedelics, Top News According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Yet, despite nearly two billion people with mental illness... Read more
